Table of Contents
<< Previous Issue | Aug 2008 (Vol: 2008, Issue: 99) | Next Issue >> |
- Section: Business Commentaries
-
US Election Will Impact New Drug Development Worldwide Forever
- Section: Distribution & Marketing
-
Cel-Sci’s Multikine Could be Distributed by Teva in Turkey and Israel
- Section: Licensing
-
Archemix in Yet Another Deal for its Aptamer Technology
-
Cytos Signs Vaccines Deal with Pfizer
-
Bristol-Myers Squibb Deal Provides PDL with Much Needed Boost
-
QLT Continues to Divest its Portfolio
-
Novosom Smarticles® to Encapsulate Isis Antisense Drugs
-
Valeant Licenses Epilepsy Drug to GSK
- Section: Mergers & Acquisitions
-
Negotiations Begin Between Bristol-Myers Squibb and ImClone
-
Valeant Pharmaceuticals’ De-Globalisation Strategy Sees the Sale of European Operations
-
The Medicines Company Acquires Curacyte and its Lead Antithrombotic
-
CSL Seeks to Solidfy its Position by Acquiring Talecris
- Section: Research & Development
-
Eli Lilly’s Novel Financing Approach to R&D